Status:
RECRUITING
French National Registry of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator
Lead Sponsor:
Paris Sudden Death Expertise Center
Conditions:
Tetralogy of Fallot
Implantable Defibrillator User
Eligibility:
All Genders
18+ years
Brief Summary
National french registry of patients with tetralogy of Fallot and implantable cardioverter defibrillator.
Detailed Description
Inclusion criteria: * patient with tetralogy of Fallot \> 18 years * implantable cardioverter defibrillator (ICD) * primary or secondary prevention All french centers performing ICD implantation are...
Eligibility Criteria
Inclusion
- tetralogy of Fallot
- implantable cardioverter defibrillator
Exclusion
- age \< 18 years
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03837574
Start Date
December 1 2010
End Date
December 31 2030
Last Update
February 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Paris Sudden Death Expertise Center
Paris, France, 75015